Nonadherence in Patients With Breast Cancer Receiving Oral Therapies

被引:33
作者
Moore, Susan [1 ]
机构
[1] MCG Oncol, Chicago, IL USA
关键词
MEDICATION ADHERENCE; CHEMOTHERAPY TREATMENT; TAMOXIFEN; WOMEN; INTERVENTIONS; BELIEFS; BENEFICIARIES; NONCOMPLIANCE; METAANALYSIS;
D O I
10.1188/10.CJON.41-47
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adherence is a potentially significant issue in oral therapy for breast cancer. Suboptimal adherence to medication regimens impacts clinical benefit and can result in treatment resistance, disease progression, and even death. Nonadherence is a greater issue with oral medications because the majority of responsibility shifts from healthcare professionals to the patient. Improving adherence to medication regimens can impact patients' likelihood of successful clinical outcomes. Many factors contribute to adherence behavior, such as complex dosing or administration requirements, cost, and a lack of understanding of the importance of adherence. Most of the factors are controlled by the patient, but nurses can play a significant role by monitoring patients, identifying potential barriers to adherence, and implementing intervention strategies. If barriers to adherence with oral therapies cannot be overcome, the use of IV therapies with equivalent efficacy and acceptable safety should be considered. Using IV medication, when available, can improve outcomes by ensuring that the patient receives the correct and optimal dose of medication at every cycle.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 52 条
[41]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[42]   Meta-analysis of trials of interventions to improve medication adherence [J].
Peterson, AM ;
Takiya, L ;
Finley, R .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (07) :657-665
[43]   Patient Adherence and Persistence With Oral Anticancer Treatment [J].
Ruddy, Kathryn ;
Mayer, Erica ;
Partridge, Ann .
CA-A CANCER JOURNAL FOR CLINICIANS, 2009, 59 (01) :56-66
[44]  
Schwartz K., 2009, SPENDING SURVIVE CAN
[45]   Challenges for improving medication adherence [J].
Simpson, Ross J., Jr. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (21) :2614-2616
[46]   Cost-related medication nonadherence among elderly and disabled medicare beneficiaries - A national survey 1 year before the medicare drug benefit [J].
Soumerai, Stephen B. ;
Pierre-Jacques, Marsha ;
Zhang, Fang ;
Ross-Degnan, Dennis ;
Adams, Alyce S. ;
Gurwitz, Jerry ;
Adler, Gerald ;
Safran, Dana Gelb .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) :1829-1835
[47]  
THOMPSON AM, 2007, ASS POOR ADHERENCE P
[48]   Interventions to improve medication compliance in older patients living in the community - A systematic review of the literature [J].
van Eijken, M ;
Tsang, S ;
Wensing, M ;
de Smet, PAGM ;
Grol, RPTM .
DRUGS & AGING, 2003, 20 (03) :229-240
[49]   The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses [J].
Vrijens, B ;
Gross, R ;
Urquhart, J .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) :225-227
[50]   ADHERENCE TO ORAL TAMOXIFEN - A COMPARISON OF PATIENT SELF-REPORT, PILL COUNTS, AND MICROELECTRONIC MONITORING [J].
WATERHOUSE, DM ;
CALZONE, KA ;
MELE, C ;
BRENNER, DE .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1189-1197